The healthcare landscape in Florida is undergoing a rapid digital transformation. Artificial intelligence is increasingly reshaping healthcare in Florida, from streamlining administrative tasks and analyzing medical data to supporting telehealth services and prescription management. In Florida, wher e telehealth and digital health services surged after the COVID-19 pandemic, AI-powered systems are becoming more common in both large hospital systems and private medical practices. However, as hospitals, clinics, and startups adopt AI tools at a rapid pace, healthcare attorneys and regulators warn that legal and privacy risks are growing just as quickly. The Telehealth Boom and Prescribing Laws Telemedicine has dramatically increased access to care for pain management, mental health, and chronic diseases. A recent study tracking appointments in the Tampa area found that telehealth appointments had a 73.4% completion rate compared to 64.2% for in-person visits, meaning patients are 64% more likely to follow through with virtual care. While virtual care increases convenience, artificial intelligence is also becoming intertwined with telehealth, which is an area that is already heavily regulated in Florida. Under Florida Statute 456.47, healthcare providers using telehealth must meet the same professional standard of care required for in-person treatment. Furthermore, the law places limits on prescribing controlled substances through telehealth. In most cases, providers may not prescribe Schedule II controlled substances remotely unless the prescription falls within specific exceptions. These narrow exceptions are limited to treating a psychiatric disorder, inpatient hospital treatment, hospice services, or treating a nursing home resident. Navigating the federal Ryan Haight Act, which traditionally mandates an initial in-person evaluation, also remains a critical compliance hurdle. AI’s Promise and Privacy Pitfalls The global healthcare AI market is projected to exceed $180 billion by 2030, according to industry estimates, as providers use artificial intelligence to improve efficiency, reduce costs, and expand patient access. Supporters say the technology has enormous potential; AI tools can assist physicians with reviewing imaging studies, summarizing medical records, predicting patient risks, and automating routine documentation. But legal experts say the technology introduces serious compliance concerns especially those involving patient privacy, intellectual property, and telemedicine laws. One growing issue involves the use of generative AI platforms to process sensitive healthcare information. Healthcare providers must strictly comply with federal patient privacy requirements under HIPAA, which restrict how protected health information may be shared or stored. Legal experts say AI-assisted telehealth systems could create additional liability risks if providers rely too heavily on automated decision-making tools without appropriate physician oversight. Despite rapid innovation, healthcare attorneys emphasize that AI remains a support tool and not a replacement for medical judgment. Protecting Medical Innovation As organizations develop these life-saving AI tools, they face the new challenge of protecting their intellectual property. Healthcare businesses often possess proprietary clinical protocols, operational systems, and confidential business information that may qualify as trade secrets under Florida law. Without public disclosure, trade secret protection offers a flexible way to safeguard these clinical assets. To qualify for protection under frameworks like the Uniform Trade Secrets Act, the information must not be publicly known, must hold economic value, and must be subject to reasonable protection measures. Simple “confidential” labels are not enough. Medical businesses must actively combat digital threats by implementing strict asset mapping, layered cybersecurity controls, and clear employee confidentiality agreements. Looking Ahead Industry experts expect AI regulation in healthcare to expand significantly over the next several years as lawmakers attempt to balance innovation with patient safety and privacy protections. For now, healthcare providers entering the AI space face a rapidly evolving legal landscape where convenience and innovation must be carefully balanced against ethical duties and regulatory compliance.     About the Author: Jamaal R. Jones, Esq., is the founder of Jones Health Law, P.A., a Florida-based law firm focused exclusively on healthcare law. He advises healthcare providers and businesses on regulatory compliance, payer disputes and reimbursement, professional licensing, healthcare transactions and business operations. Jones is also an Adjunct Professor of health law at the University of Tennessee Winston College of Law, a former chair of The Florida Bar Health Law Section, and current Vice Chair of Physician Organization Practice Group for the American Health Lawyer’s Association. He also has a YouTube page and Podcast aptly called “Jones Health Law” where he discusses healthcare law issues and interviews healthcare practitioners. (305) 877-5054; @joneshealthlaw; [email protected]—The post The Promise and Peril of Artificial Intelligence in Florida Healthcare first appeared on Miami’s Community News.The post The Promise and Peril of Artificial Intelligence in Florida Healthcare appeared first on Miami’s Community News. ...read more read less